linsidomine has been researched along with n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersson, KE; Persson, K; Waldeck, K | 1 |
Gambino, A; Thomas, BJ; Wanstall, JC | 1 |
Högestätt, ED; Petersson, J; Ryman, T | 1 |
3 other study(ies) available for linsidomine and n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate
Article | Year |
---|---|
Effects of KRN2391, a novel vasodilator acting as a nitrate and a K+ channel opener, on the rabbit lower urinary tract.
Topics: Animals; Benzopyrans; Cromakalim; Cyclic GMP; Electrophysiology; Female; Hypoglycemic Agents; Molsidomine; Muscle Relaxation; Muscle, Smooth; Pyridines; Pyrroles; Rabbits; Urethra; Vasodilator Agents | 1995 |
KRN2391: dual action on rat pulmonary artery and no loss of potency in pulmonary hypertension.
Topics: Adenosine Triphosphate; Animals; Cromakalim; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Guanylate Cyclase; Humans; Hypertension, Pulmonary; Hypoglycemic Agents; In Vitro Techniques; Infant, Newborn; Male; Methylene Blue; Molsidomine; Nitric Oxide Donors; Potassium Channels; Pulmonary Artery; Pyridines; Rats; Rats, Wistar; Vasodilation; Vasodilator Agents | 2000 |
Vasodilator effects of KRN2391, levcromakalim and 3-morpholino-sydnonimin in human pial and omental arteries.
Topics: Aged; Arteries; ATP-Binding Cassette Transporters; Cromakalim; Enzyme Inhibitors; Guanylate Cyclase; Humans; In Vitro Techniques; KATP Channels; Middle Aged; Molsidomine; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Omentum; Pia Mater; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pyridines; Regional Blood Flow; Vasodilator Agents | 2000 |